These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Frontal cortex as the site of action of physostigmine in nbM-lesioned rats. Haroutunian V; Mantin R; Kanof PD Physiol Behav; 1990 Jan; 47(1):203-6. PubMed ID: 2326337 [TBL] [Abstract][Full Text] [Related]
7. Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats. Riekkinen P; Sirviö J; Riekkinen M; Riekkinen P Pharmacol Biochem Behav; 1991 Aug; 39(4):841-6. PubMed ID: 1763101 [TBL] [Abstract][Full Text] [Related]
8. Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions. Miyamoto M; Narumi S; Nagaoka A; Coyle JT J Pharmacol Exp Ther; 1989 Feb; 248(2):825-35. PubMed ID: 2918482 [TBL] [Abstract][Full Text] [Related]
9. NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems. Ogasawara T; Itoh Y; Tamura M; Ukai Y; Yoshikuni Y; Kimura K Pharmacol Biochem Behav; 1996 Feb; 53(2):391-9. PubMed ID: 8808149 [TBL] [Abstract][Full Text] [Related]
10. Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats. Santucci AC; Kanof PD; Haroutunian V Psychopharmacology (Berl); 1989; 99(1):70-4. PubMed ID: 2506606 [TBL] [Abstract][Full Text] [Related]
11. Interactions of forebrain cholinergic and somatostatinergic systems in the rat. Haroutunian V; Kanof PD; Davis KL Brain Res; 1989 Sep; 496(1-2):98-104. PubMed ID: 2804656 [TBL] [Abstract][Full Text] [Related]
12. Reversal of learning and memory impairments following lesion of the nucleus basalis magnocellularis (NBM) by concurrent noradrenergic depletion using DSP4 in the rat. Moran PM; LeMaître MH; Philouze V; Reymann JM; Allain H; Leonard BE Brain Res; 1992 Nov; 595(2):327-33. PubMed ID: 1281740 [TBL] [Abstract][Full Text] [Related]
13. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers. Mandel RJ; Chen AD; Connor DJ; Thal LJ J Pharmacol Exp Ther; 1989 Nov; 251(2):612-9. PubMed ID: 2810114 [TBL] [Abstract][Full Text] [Related]
14. Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies. Bartus RT; Flicker C; Dean RL; Pontecorvo M; Figueiredo JC; Fisher SK Pharmacol Biochem Behav; 1985 Jul; 23(1):125-35. PubMed ID: 4041042 [TBL] [Abstract][Full Text] [Related]
16. Loss of nucleus basalis magnocellularis, but not septal, cholinergic neurons correlates with passive avoidance impairment in rats treated with 192-saporin. Zhang ZJ; Berbos TG; Wrenn CC; Wiley RG Neurosci Lett; 1996 Jan; 203(3):214-8. PubMed ID: 8742031 [TBL] [Abstract][Full Text] [Related]
17. Cholinergic ventral forebrain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer disease. Fine A; Dunnett SB; Björklund A; Iversen SD Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5227-30. PubMed ID: 3860857 [TBL] [Abstract][Full Text] [Related]
18. Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats. Kwo-On-Yuen PF; Mandel R; Chen AD; Thal LJ Exp Neurol; 1990 Jun; 108(3):221-8. PubMed ID: 2351210 [TBL] [Abstract][Full Text] [Related]
19. Cholinergic drugs regulate passive avoidance performance via the amygdala. Riekkinen P; Riekkinen M; Sirviö J J Pharmacol Exp Ther; 1993 Dec; 267(3):1484-92. PubMed ID: 8263810 [TBL] [Abstract][Full Text] [Related]
20. Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis. Murray CL; Fibiger HC Behav Neurosci; 1986 Feb; 100(1):23-32. PubMed ID: 3954876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]